Genentech and Roche Break Ground on US Manufacturing Facility
The $700 million project is part of Genentech and Roche’s $50 billion investment in U.S. manufacturing, infrastructure and R&D
investment
Cambrex Expands Peptide Manufacturing Capabilities in US
CDMO Cambrex announced that Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts
29.08.2025 • News
Arkema Invests $60 Million in New Fluorospecialties Production Unit in the US
With the start-up of its production unit in Kentucky, Arkema develops its low Global Warming Potential (GWP) fluorospecialties to meet demand for more sustainable solutions in building insulation and thermal management.
AbbVie to Acquire Gilgamesh Pharmaceutical’s Psychedelic Drug for $1.2B
Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD).
Sumitomo Scales Up Ethanol-to-Propylene Process
Sumitomo Chemical has constructed and begun operation of a pilot facility at the Sodegaura site of its Chiba Works for its new proprietary process to produce propylene directly from ethanol.
14.08.2025 • News
Nouryon Expands Sodium Chlorate Capacity in South America by 20%
Nouryon has signed a long-term agreement with Arauco for the supply of sodium chlorate and chlorine dioxide for Arauco's new $4.6 billion pulp mill in Mato Grosso do Sul, Brazil.
AbbVie Invests $195 Million in US API Production
AbbVie announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the US.
Chevron Phillips Chemical Completes PAO Expansion in Belgium
Chevron Phillips Chemical has successfully completed the expansion of its low-viscosity polyalphaolefins production unit in Beringen, Belgium, boosting its manufacturing capacity in Europe.
12.08.2025 • News • Bioprocessing
Bionova Scientific Opens New pDNA Facility in Texas
Bionova Scientific has opened a 10,000 square-foot state-of-the-art plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.
29.07.2025 • News • Bioprocessing
Asahi Kasei Expands Planova Production with New Spinning Plant
Asahi Kasei Life Science, a division of global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova virus removal filters in Nobeoka City, Miyazaki, Japan.
Boehringer Ingelheim Paves the Way for Important Market Launches
Boehringer Ingelheim recorded positive growth in the first half of 2025 with an increase in Group sales of 6.3% to € 14 billion.
Sygnature Discovery Unveils £1 Million Chemistry Facility Upgrade
Sygnature Discovery, an integrated drug discovery CRO, has completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory infrastructure following a £1 million investment.
AstraZeneca to Invest $50 Billion in US Manufacturing
AstraZeneca recently announced $50 billion of investment in the US by 2030. This investment is expected to create tens of thousands of new, highly skilled jobs nationwide.
Sanner Opens its First US Production Facility in North Carolina
Sanner, a provider of high-quality healthcare packaging and drug delivery solutions, officially opened its first US-based production facility in Greensboro, North Carolina.
Ineos Invests £30 Million to Slash Emissions at Hull Site by 75%
Ineos has completed a major £30 million investment at its Hull manufacturing site, converting the facility to run on clean-burning hydrogen instead of natural gas. This results in a 75% cut in carbon emissions.
16.07.2025 • News
Flamma Opens New cGMP Plant in China
The Flamma Group, a Contract Development and Manufacturing Organization (CDMO), recently celebrated the grand opening of a new cGMP plant in Dalian, China.
10.07.2025 • News
Arkema Invests in New Polyamide Unit in Singapore
Arkema is building an additional unit at its Singapore site to produce Rilsan Clear, a transparent polyamide. With an investment of $20 million, the site is expected to open in early 2026.
10.07.2025 • News • Bioprocessing
Wacker Opens Biotechnology Center in Munich
In a new building at the Wacker Consortium, the company's central research site, researchers are working on new manufacturing processes for biopharmaceuticals and ingredients for food and nutritional supplements.
09.07.2025 • News
IMCD Opens New Life Science Hub in Shanghai
IMCD recently announced the opening of its newly reorganised and expanded Life Science Laboratory hub in Shanghai.
Pace Life Sciences Expands Sterile Filling Capabilities
Pace Life Sciences, a US-based contract research, development, and manufacturing organization (CRDMO), is remodeling and expanding its Salem, NH site for aseptic fill-finish processing.
07.07.2025 • News
WeylChem Launches Advanced Materials Line and Partners with Novoset
WeylChem Wesseling has announced its entry into the Advanced Materials market with the formation of a new Advanced Materials Business Line in Germany.
Mitsubishi Chemical Group Launches Chemical Recycling Plant for Plastic-to-Oil Conversion
ENEOS and Mitsubishi Chemical have completed their chemical recycling facility at Mitsubishi Chemical’s Ibaraki Plant in Kamisu City, Ibaraki Prefecture, Japan.
04.07.2025 • News
Nippon Shokubai to Boost Nucleic Acid Drug API Output Tenfold
Nippon Shokubai recently announced plans to expand its GMP-compliant manufacturing capacity for nucleic acid drug active pharmaceutical ingredients (APIs) tenfold.
04.07.2025 • News
CATL and Partners Launch $6 Billion Battery Integration Project in Indonesia
CATL and its partners have started construction on a $6 billion battery integration project in West Java, Indonesia.
04.07.2025 • News
Hikma Invests $1 Billion to Expand US Generics Manufacturing
Hikma Pharmaceuticals USA announces $1 billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines.
03.07.2025 • News • Bioprocessing
Sanofi Builds Modern Office at BioCampus Frankfurt
The biopharmaceutical company Sanofi in Germany and the industrial park operator Infraserv Höchst laid the foundation stone for a state-of-the-art office building in the south of the industrial park.
03.07.2025 • News • Bioprocessing
AGC Biologics Expands Cell Therapy Development Operations to Asia
AGC Biologics began its cell therapy process development and clinical manufacturing services on July 1, 2025, at its Yokohama Technical Center in Japan.
Solvay Joint Venture Invests in Production Unit in Chile
Peróxidos do Brasil, a joint venture between Solvay and Produtos Químicos Makay (PQM), announces a new strategic investment in its production unit in Chile.
Axplora Announces €35 Million Expansion at Farmabios
Axplora to expand its Farmabios site in Gropello Cairoli, Italy, with a €35 million investment.
Pharma Service Provider Vetter Establishes New Site in Chicago
Vetter broke ground for the start of construction of its new clinical site in Des Plaines, Illinois, US on June 26.
30.06.2025 • News
Aenova Expands its Refrigerated Logistics for Biologics
Aenova is investing in a new cold storage infrastructure at its sterile site in Latina (Italy), offering an end-to-end supply chain solution for biologics and other pharmaceutical products.
Sika Acquires Gulf Additive Factory
Sika has acquired Gulf Additive Factory in the State of Qatar. The company manufactures a wide range of construction chemical products.
Celltrion Opens UK Headquarters in Uxbridge
Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK.
Nouryon Launches Innovation Center for Oilfield Solutions in US
The Innovation Center will focus on research and development for sustainable drilling and completion, production, and stimulation processes, and will also serve as a platform for workshops and training sessions.
24.06.2025 • News
Neoenergia Begins One of the First Green Hydrogen Supply Units in Brazil
Neoenergia began construction of one of the first green hydrogen (H2V) power plants Brazil, located in Taguatinga with an investment of more than R$ 30 million (€ 4.7 million).
